Buddingh EP - Search Results

1

Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study.

Tsilifis C, Speckmann C, Lum SH, Fox TA, Soler AM, Mozo Y, Corral D, Ewins AM, Hague R, Oikonomopoulou C, Kałwak K, Drabko K, Wynn R, Morris EC, Elcombe S, Bigley V, Lougaris V, Malagola M, Hauck F, Sedlacek P, Laberko A, Tjon JML, Buddingh EP, Wehr C, Grimbacher B, Gennery AR, Lankester AC, Albert MH, Neven B, Slatter MA. Tsilifis C, et al. Among authors: buddingh ep. J Allergy Clin Immunol. 2024 Dec;154(6):1534-1544. doi: 10.1016/j.jaci.2024.08.020. Epub 2024 Aug 30. J Allergy Clin Immunol. 2024. PMID: 39218359 Free article.

2

[COVID-19-associated hyperinflammatory state in a 15-year-old female patient].

Blink M, Buddingh' EP, Filippini LHPM, Brinkman DMC, Joosten SA, Klein RH. Blink M, et al. Among authors: buddingh ep. Ned Tijdschr Geneeskd. 2020 Oct 22;164:D5348. Ned Tijdschr Geneeskd. 2020. PMID: 33331715 Dutch.

3

Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy.

Kuijjer ML, van den Akker BE, Hilhorst R, Mommersteeg M, Buddingh EP, Serra M, Bürger H, Hogendoorn PC, Cleton-Jansen AM. Kuijjer ML, et al. Among authors: buddingh ep. BMC Med Genomics. 2014 Jan 21;7:4. doi: 10.1186/1755-8794-7-4. BMC Med Genomics. 2014. PMID: 24447333 Free PMC article.

4

Severe Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children From Wild-type to Population Immunity: A Prospective Multicenter Cohort Study With Real-time Reporting.

Tulling AJ, Lugthart G, Mooij MG, Brackel CLH, Terheggen-Lagro SWJ, Oostenbrink R, Buysse CMP, Hashimoto S, Armbrust W, Bannier MAGE, Bekhof J, van Gameren-Oosterom HB, Hendriks H, van Houten MA, van der Linden JW, Lebon A, van Onzenoort-Bokken L, Tramper-Stranders GA, van Veen M, von Asmuth EGJ, Buddingh EP; COPP-study group. Tulling AJ, et al. Among authors: buddingh ep. Pediatr Infect Dis J. 2023 Dec 1;42(12):1077-1085. doi: 10.1097/INF.0000000000004098. Epub 2023 Oct 12. Pediatr Infect Dis J. 2023. PMID: 37823702 Free PMC article.

5

Prognostic factors in pulmonary metastasized high-grade osteosarcoma.

Buddingh EP, Anninga JK, Versteegh MI, Taminiau AH, Egeler RM, van Rijswijk CS, Hogendoorn PC, Lankester AC, Gelderblom H. Buddingh EP, et al. Pediatr Blood Cancer. 2010 Feb;54(2):216-21. doi: 10.1002/pbc.22293. Pediatr Blood Cancer. 2010. PMID: 19890902

6

Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells.

Buddingh EP, Schilham MW, Ruslan SE, Berghuis D, Szuhai K, Suurmond J, Taminiau AH, Gelderblom H, Egeler RM, Serra M, Hogendoorn PC, Lankester AC. Buddingh EP, et al. Cancer Immunol Immunother. 2011 Apr;60(4):575-86. doi: 10.1007/s00262-010-0965-3. Epub 2011 Jan 15. Cancer Immunol Immunother. 2011. PMID: 21240486 Free PMC article.

7

Tumor-infiltrating macrophages are associated with metastasis suppression in high-grade osteosarcoma: a rationale for treatment with macrophage activating agents.

Buddingh EP, Kuijjer ML, Duim RA, Bürger H, Agelopoulos K, Myklebost O, Serra M, Mertens F, Hogendoorn PC, Lankester AC, Cleton-Jansen AM. Buddingh EP, et al. Clin Cancer Res. 2011 Apr 15;17(8):2110-9. doi: 10.1158/1078-0432.CCR-10-2047. Epub 2011 Mar 3. Clin Cancer Res. 2011. PMID: 21372215

8

Anti-EGFR antibody cetuximab enhances the cytolytic activity of natural killer cells toward osteosarcoma.

Pahl JH, Ruslan SE, Buddingh EP, Santos SJ, Szuhai K, Serra M, Gelderblom H, Hogendoorn PC, Egeler RM, Schilham MW, Lankester AC. Pahl JH, et al. Among authors: buddingh ep. Clin Cancer Res. 2012 Jan 15;18(2):432-41. doi: 10.1158/1078-0432.CCR-11-2277. Epub 2011 Nov 16. Clin Cancer Res. 2012. PMID: 22090361

9

Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients.

Buddingh EP, Ruslan SE, Berghuis D, Gelderblom H, Anninga JK, Hogendoorn PC, Egeler RM, Schilham MW, Lankester AC. Buddingh EP, et al. Cancer Immunol Immunother. 2012 Jun;61(6):941-7. doi: 10.1007/s00262-012-1232-6. Epub 2012 Mar 10. Cancer Immunol Immunother. 2012. PMID: 22402907 Free PMC article.

10

Histone deacetylase inhibitors enhance expression of NKG2D ligands in Ewing sarcoma and sensitize for natural killer cell-mediated cytolysis.

Berghuis D, Schilham MW, Vos HI, Santos SJ, Kloess S, Buddingh' EP, Egeler RM, Hogendoorn PC, Lankester AC. Berghuis D, et al. Among authors: buddingh ep. Clin Sarcoma Res. 2012 Feb 8;2(1):8. doi: 10.1186/2045-3329-2-8. Clin Sarcoma Res. 2012. PMID: 22587892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters